Molecular docking and dynamics simulation of Orthosiphon stamineus against SGLT1 and SGLT2

References

• Abdul-Ghani, M. A., Norton, L., & DeFronzo, R. A. (2015). Renal sodium-glucose cotransporter inhibition in the management of type 2 diabetes mellitus. American Journal of Physiology-Renal Physiology, 309(11), F889–F900. https://doi.org/10.1152/ajprenal.00267.2015
   PubMed Web of Science ®Google Scholar
• Ashraf, K., Sultan, S., & Adam, A. (2018). Orthosiphon stamineus Benth. is an outstanding food medicine: Review of phytochemical and pharmacological activities. Journal of Pharmacy & Bioallied Sciences, 10(3), 109–118.
   PubMed Web of Science ®Google Scholar
• Avanza, T. (2020). Forxiga cardiovascular outcomes benefit approved in China (Cision). Update, 8, 01.
   Google Scholar
• Borad, M. A., Jethava, D. J., Bhoi, M. N., Patel, C. N., Pandya, H. A., & Patel, H. D. (2020). Novel isoniazid-spirooxindole derivatives: Design, synthesis, biological evaluation, in silico ADMET prediction and computational studies. Journal of Molecular Structure, 1222, 128881. https://doi.org/10.1016/j.molstruc.2020.128881
   Web of Science ®Google Scholar
• Bordoli, L., Kiefer, F., Arnold, K., Benkert, P., Battey, J., & Schwede, T. (2009). Protein structure homology modeling using SWISS-MODEL workspace. Nature Protocols, 4(1), 1–13. https://doi.org/10.1038/nprot.2008.197
   PubMed Web of Science ®Google Scholar
• Coffey, A., & Meek, A. (XXXX). JARDIANCE® (empagliflozin) becomes the first and only approved treatment in Canada for adults with chronic heart failure regardless of ejection fraction.
   Google Scholar
• Costa, C. R., Olivi, P., Botta, C. M., & Espindola, E. L. (2008). Toxicity in aquatic environments: discussion and evaluation methods. Química Nova, 31(7), 1820–1830. https://doi.org/10.1590/S0100-40422008000700038
   Web of Science ®Google Scholar
• Fatima, S., Gupta, P., Sharma, S., Sharma, A., & Agarwal, S. M. (2020). ADMET profiling of geographically diverse phytochemical using chemoinformatic tools. Future Medicinal Chemistry, 12(1), 69–87. https://doi.org/10.4155/fmc-2019-0206
   PubMed Web of Science ®Google Scholar
• Filimonov, D. A., Akimov, D. V., & Poroikov, V. V. (2004). The method of self-consistent regression for the quantitative analysis of relationships between structure and properties of chemicals. Pharmaceutical Chemistry Journal, 38(1), 21–24. https://doi.org/10.1023/B:PHAC.0000027639.17115.5d
   Google Scholar
• Fretwell, T., & Bell, A. (2019). Mundipharma announces launch of INVOKANA® and VOKANAMET® in Norway for the treatment of type 2 diabetes as part of exclusive distribution agreement with Janssen.
   Google Scholar
• Goddard, T. D., Huang, C. C., & Ferrin, T. E. (2007). Visualizing density maps with UCSF Chimera. Journal of Structural Biology, 157(1), 281–287.
   PubMed Web of Science ®Google Scholar
• Gohlke, H., Hendlich, M., & Klebe, G. (2000). Knowledge-based scoring function to predict protein-ligand interactions. Journal of Molecular Biology, 295(2), 337–356.
   PubMed Web of Science ®Google Scholar
• Gupta, M., Kant, K., Sharma, R., & Kumar, A. (2018). Evaluation of in silico anti-parkinson potential of β-asarone. Central Nervous System Agents in Medicinal Chemistry, 18(2), 128–135. https://doi.org/10.2174/1871524918666180416153742
   PubMedGoogle Scholar
• Haas, B., Eckstein, N., Pfeifer, V., Mayer, P., & Hass, M. D. S. (2014). Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin. Nutrition & Diabetes, 4(11), e143. https://doi.org/10.1038/nutd.2014.40
   PubMedGoogle Scholar
• Hakami, A. R. (2022). Targeting the RBD of omicron variant (B. 1.1. 529) with medicinal phytocompounds to abrogate the binding of spike glycoprotein with the hACE2 using computational molecular search and simulation approach. Biology, 11(2), 258. https://doi.org/10.3390/biology11020258
   PubMedGoogle Scholar
• Han, Y., Zhang, J., Hu, C. Q., Zhang, X., Ma, B., & Zhang, P. (2019). In silico ADME and toxicity prediction of ceftazidime and its impurities. Frontiers in Pharmacology, 10, 434. https://doi.org/10.3389/fphar.2019.00434
   PubMed Web of Science ®Google Scholar
• Hanwell, M. D., Curtis, D. E., Lonie, D. C., Vandermeersch, T., Zurek, E., & Hutchison, G. R. (2012). Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. Journal of Cheminformatics, 4(1), 1–17. https://doi.org/10.1186/1758-2946-4-17
   PubMedGoogle Scholar
• Jiménez, J., Doerr, S., Martínez-Rosell, G., Rose, A. S., & De Fabritiis, G. (2017). DeepSite: protein-binding site predictor using 3D-convolutional neural networks. Bioinformatics, 33(19), 3036–3042. https://doi.org/10.1093/bioinformatics/btx350
   PubMed Web of Science ®Google Scholar
• Jaén-Gil, A., Buttiglieri, G., Benito, A., Mir-Tutusaus, J. A., Gonzalez-Olmos, R., Caminal, G., Barceló, D., Sarrà, M., & Rodriguez-Mozaz, S. (2021). Combining biological processes with UV/H2O2 for metoprolol and metoprolol acid removal in hospital wastewater. Chemical Engineering Journal, 404, 126482. https://doi.org/10.1016/j.cej.2020.126482
   Web of Science ®Google Scholar
• Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., Wang, J., Yu, B., Zhang, J., & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic Acids Research, 44(D1), D1202–D1213. https://doi.org/10.1093/nar/gkv951
   PubMed Web of Science ®Google Scholar
• Koche, D., Shirsat, R., & Kawale, M. A. H. E. S. H. (2016). An overerview of major classes of phytochemicals: their types and role in disease prevention. Hislopia Journal, 9(1/2), 0976–2124.
   Google Scholar
• Lagunin, A., Zakharov, A., Filimonov, D., & Poroikov, V. (2011). QSAR modelling of rat acute toxicity on the basis of PASS prediction. Molecular Informatics, 30(2–3), 241–250. https://doi.org/10.1002/minf.201000151
   PubMed Web of Science ®Google Scholar
• Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993). PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography, 26(2), 283–291. https://doi.org/10.1107/S0021889892009944
   Web of Science ®Google Scholar
• Li, G., Shao, K., & Umeshappa, C. S. (2019). Recent progress in blood-brain barrier transportation research. Brain Targeted Drug Delivery System, 33–51.
   Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2012). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 64, 4–17. https://doi.org/10.1016/j.addr.2012.09.019
   Web of Science ®Google Scholar
• Macalalad, M. A. B., & Gonzales III, A. A. (2021). In-silico screening and identification of phytochemicals from Centella asiatica as potential inhibitors of sodium-glucose co-transporter 2 for treating diabetes. Journal of Biomolecular Structure and Dynamics, 40(22), 12221–12238.
   PubMed Web of Science ®Google Scholar
• Mahanthesh, M. T., Ranjith, D., Yaligar, R., Jyothi, R., Narappa, G., & Ravi, M. V. (2020). Swiss ADME prediction of phytochemicals present in Buteamonosperma (Lam.) Taub. Journal of Pharmacognosy and Phytochemistry, 9(3), 1799–1809.
   Google Scholar
• Marino, A. M., Yarde, M., Patel, H., Chong, S., & Balimane, P. V. (2005). Validation of the 96 well Caco-2 cell culture model for high throughput permeability assessment of discovery compounds. International Journal of Pharmaceutics, 297(1–2), 235–241. https://doi.org/10.1016/j.ijpharm.2005.03.008
   PubMed Web of Science ®Google Scholar
• May, M., & Schindler, C. (2016). Clinically and pharmacologically relevant interactions of antidiabetic drugs. Therapeutic Advances in Endocrinology and Metabolism, 7(2), 69–83. https://doi.org/10.1177/2042018816638050
   PubMed Web of Science ®Google Scholar
• McElvany, K. D. (2009). FDA requirements for preclinical studies. In Clinical trials in the neurosciences (Vol. 25, pp. 46–49). Karger Publishers.
   Google Scholar
• Meng, X. Y., Zhang, H. X., Mezei, M., & Cui, M. (2011). Molecular docking: a powerful approach for structure-based drug discovery. Current Computer Aided-Drug Design, 7(2), 146–157. https://doi.org/10.2174/157340911795677602
   PubMed Web of Science ®Google Scholar
• Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/10.1002/jcc.21256
   PubMed Web of Science ®Google Scholar
• Muegge, I., Heald, S. L., & Brittelli, D. (2001). Simple selection criteria for drug-like chemical matter. Journal of Medicinal Chemistry, 44(12), 1841–1846.
   PubMed Web of Science ®Google Scholar
• Nelinson, D. S., Sosa, J. M., & Chilton, R. J. (2021). SGLT2 inhibitors: a narrative review of efficacy and safety. Journal of Osteopathic Medicine, 121(2), 229–239. https://doi.org/10.1515/jom-2020-0153
   PubMedGoogle Scholar
• Nguyen, N. T., Nguyen, T. H., Pham, T. N. H., Huy, N. T., Bay, M. V., Pham, M. Q., Nam, P. C., Vu, V. V., & Ngo, S. T. (2020). Autodock vina adopts more accurate binding poses but autodock4 forms better binding affinity. Journal of Chemical Information and Modeling, 60(1), 204–211. https://doi.org/10.1021/acs.jcim.9b00778
   PubMed Web of Science ®Google Scholar
• Oany, A. R., Ahmad, S. A. I., Siddikey, M. A. A., Hossain, M. U., & Ferdoushi, A. (2014). Computational structure analysis and function prediction of an uncharacterized protein (I6U7D0) of Pyrococcus furiosus Com1. Austin J Comput Biol Bioinform, 1(2), 5.
   Google Scholar
• Ojo, O. A., Ojo, A. B., Okolie, C., Nwakama, M.-A C., Iyobhebhe, M., Evbuomwan, I. O., Nwonuma, C. O., Maimako, R. F., Adegboyega, A. E., Taiwo, O. A., Alsharif, K. F., & Batiha, G. E.-S. (2021). Deciphering the interactions of bioactive compounds in selected traditional medicinal plants against Alzheimer’s diseases via pharmacophore modeling, auto-QSAR, and molecular docking approaches. Molecules, 26(7), 1996. https://doi.org/10.3390/molecules26071996
   PubMed Web of Science ®Google Scholar
• Oliva, F., Musiani, F., Giorgetti, A., De Rubeis, S., Sorokina, O., Armstrong, J. D., … Ruggerone, P. (2022). ModelingeNvironment for Isoforms (MoNvIso): A general platform to predict structural determinants of protein isoforms in genetic diseases. bioRxiv, 2022-04.
   Google Scholar
• Patel, C. N., Jani, S. P., Jaiswal, D. G., Kumar, S. P., Mangukia, N., Parmar, R. M., Rawal, R. M., & Pandya, H. A. (2021). Identification of antiviral phytochemicals as a potential SARS-CoV-2 main protease (Mpro) inhibitor using docking and molecular dynamics simulations. Scientific Reports, 11(1), 1–13. https://doi.org/10.1038/s41598-021-99165-4
   PubMed Web of Science ®Google Scholar
• Pontius, J., Richelle, J., & Wodak, S. J. (1996). Deviations from standard atomic volumes as a quality measure for protein crystal structures. Journal of Molecular Biology, 264(1), 121–136.
   PubMed Web of Science ®Google Scholar
• Poroikov, V. V., Filimonov, D. A., Borodina, Y. V., Gloriozova, T. A., Sitnikov, V. B., Sadovnikov, S. V., & Sosnov, A. V. (2004). Quantitative relationships between structure and delayed neurotoxicity of chemicals studied by the Self-Consistent Regression method using the PASS program. Pharmaceutical Chemistry Journal, 38(4), 188–190. https://doi.org/10.1023/B:PHAC.0000038416.33964.dc
   Google Scholar
• Prasad, S., Sajja, R. K., Naik, P., & Cucullo, L. (2014). Diabetes mellitus and blood-brain barrier dysfunction: an overview. Journal of Pharmacovigilance, 2(2), 125.
   PubMedGoogle Scholar
• Rachmania, R. A., Supandi, S., & Larasati, O. A. (2015). Analisis in-silico senyawa diterpenoid lakton herba sambiloto (Andrographis Paniculata Nees) pada reseptor alpha-glucosidase sebagai antidiabetes tipe II. Pharmacy: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 12(2), 210–222.
   Google Scholar
• Rai, H., Barik, A., Singh, Y. P., Suresh, A., Singh, L., Singh, G., Nayak, U. Y., Dubey, V. K., & Modi, G. (2021). Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19. Molecular Diversity, 25(3), 1905–1927. https://doi.org/10.1007/s11030-021-10188-5
   PubMed Web of Science ®Google Scholar
• Rajalakshmi, R., Lalitha, P., Sharma, S. C., Rajiv, A., Chithambharan, A., & Ponnusamy, A. (2021). In Silico studies: Physicochemical properties, drug score, toxicity predictions and molecular docking of organosulphur compounds against Diabetes mellitus. Journal of Molecular Recognition, 34(11), e2925. https://doi.org/10.1002/jmr.2925
   PubMed Web of Science ®Google Scholar
• Ramachandran, S., Kota, P., Ding, F., & Dokholyan, N. V. (2011). Automated minimization of steric clashes in protein structures. Proteins: Structure, Function, and Bioinformatics, 79(1), 261–270. https://doi.org/10.1002/prot.22879
   PubMed Web of Science ®Google Scholar
• Rappé, A. K., Casewit, C. J., Colwell, K. S., Goddard III, W. A., & Skiff, W. M. (1992). UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. Journal of the American Chemical Society, 114(25), 10024–10035. https://doi.org/10.1021/ja00051a040
   Web of Science ®Google Scholar
• Rose, A. S., & Hildebrand, P. W. (2015). NGL Viewer: a web application for molecular visualization. Nucleic Acids Research, 43(W1), W576–W579. https://doi.org/10.1093/nar/gkv402
   PubMed Web of Science ®Google Scholar
• Sharma, A., Mittal, S., Aggarwal, R., & Chauhan, M. K. (2020). Diabetes and cardiovascular disease: inter-relation of risk factors and treatment. Future Journal of Pharmaceutical Sciences, 6(1), 1–19. https://doi.org/10.1186/s43094-020-00151-w
   Web of Science ®Google Scholar
• Singh, M., & Kumar, A. (2018). Risks associated with SGLT2 inhibitors: an overview. Current Drug Safety, 13(2), 84–91. https://doi.org/10.2174/1574886313666180226103408
   PubMed Web of Science ®Google Scholar
• Singh, M., Sharma, R., & Kumar, A. (2019). Safety of SGLT2 inhibitors in patients with diabetes mellitus. Current Drug Safety, 14(2), 87–93. https://doi.org/10.2174/1574886314666190206164647
   PubMed Web of Science ®Google Scholar
• Tahara, A., Takasu, T., Yokono, M., Imamura, M., & Kurosaki, E. (2016). Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects. Journal of Pharmacological Sciences, 130(3), 159–169. https://doi.org/10.1016/j.jphs.2016.02.003
   PubMed Web of Science ®Google Scholar
• Thai, K. M., Ngo, T. D., Tran, T. D., & Le, M. T. (2013). Pharmacophore modeling for antitargets. Current Topics in Medicinal Chemistry, 13(9), 1002–1014. https://doi.org/10.2174/1568026611313090004
   PubMed Web of Science ®Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
   PubMed Web of Science ®Google Scholar
• Vyas, V., Jain, A., Jain, A., & Gupta, A. (2008). Virtual screening: a fast tool for drug design. ScientiaPharmaceutica, 76(3), 333–360.
   Google Scholar
• Wang, Q., Wang, J., Li, N., Liu, J., Zhou, J., Zhuang, P., & Chen, H. (2022). A systematic review of Orthosiphon stamineus Benth in the treatment of diabetes and its complications. Molecules, 27(2), 444. https://doi.org/10.3390/molecules27020444
   PubMed Web of Science ®Google Scholar
• Wu, P., Nielsen, T. E., & Clausen, M. H. (2016). Small-molecule kinase inhibitors: an analysis of FDA-approved drugs. Drug Discovery Today, 21(1), 5–10. https://doi.org/10.1016/j.drudis.2015.07.008
   PubMed Web of Science ®Google Scholar